Pages that link to "Q46618894"
Jump to navigation
Jump to search
The following pages link to Rapamycin ameliorates experimental autoimmune myocarditis (Q46618894):
Displaying 11 items.
- Mammalian target of rapamycin (mTOR) inhibitors: potential uses and a review of haematological adverse effects (Q33393707) (← links)
- IL-1beta-driven ST2L expression promotes maturation resistance in rapamycin-conditioned dendritic cells (Q33551489) (← links)
- Fatal giant cell myocarditis in a patient with multiple autoimmune disorders (Q34530643) (← links)
- Rapamycin: something old, something new, sometimes borrowed and now renewed (Q36922923) (← links)
- Novel Effects of Macrolide Antibiotics on Cardiovascular Diseases (Q37964006) (← links)
- Major involvement of mTOR in the PPARγ-induced stimulation of adipose tissue lipid uptake and fat accretion (Q42154664) (← links)
- Modulating autophagy improves cardiac function in a rat model of early-stage dilated cardiomyopathy (Q44941676) (← links)
- Rosiglitazone-induced heart remodelling is associated with enhanced turnover of myofibrillar protein and mTOR activation. (Q46034890) (← links)
- Angiotensin II receptor antagonism reverts the selective cardiac BNP upregulation and secretion observed in myocarditis (Q46648138) (← links)
- PPARγ activation attenuates glucose intolerance induced by mTOR inhibition with rapamycin in rats. (Q51325820) (← links)
- Mortality and morbidity in different immunization protocols for experimental autoimmune myocarditis in rats. (Q52880343) (← links)